Evidence map›Paper›PMID 25785607›Full record

SynthesisPLoS genetics2015

A meta-analysis of gene expression signatures of blood pressure and hypertension.

Tianxiao Huan, Tõnu Esko, Marjolein J Peters, Luke C Pilling, Katharina Schramm, Claudia Schurmann, Brian H Chen, Chunyu Liu, Roby Joehanes, Andrew D Johnson and 36 more

Registry-linked trialOpen access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03225183 (An RNA Sequencing Study in the Framingham Heart Study Third Generation Cohort Exam 2), which is not on this map. Cited by 80 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 3 pooled it
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03225183 completednot on this mapstarted 2017, after this paper: background citation

An RNA Sequencing Study in the Framingham Heart Study Third Generation Cohort Exam 2

TypeobservationalSponsorNational Heart, Lung, and Blood Institute (NHLBI)Ran2017 to 2019Enrolled1,700ConditionsCardiovascular Disease, Hypertension
3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 3 syntheses or guidelines pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Genome-Wide Meta-Analysis of Blood Pressure Response to βJournal of the American Heart Association · 2019
    Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Epigenomics and transcriptomics association study of blood pressure and incident diagnosis of hypertension in twins.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Article
  9. Article
  10. Article
  11. Treating Cardiovascular Disorders with Personalized Medicine.Cardiovascular & hematological disorders drug targets · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Immune and inflammatory mechanisms in hypertension.Nature reviews. Cardiology · 2024
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors at 17 institutions in 6 countries.

Tianxiao HuanThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, United States of America; The Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States of America.
Tõnu EskoEstonian Genome Center, University of Tartu, Tartu, Estonia; Division of Endocrinology, Children's Hospital Boston, Boston, Massachusetts, United States of America; Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America; Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America.
Marjolein J PetersDepartment of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands; Netherlands Genomics Initiative-sponsored Netherlands Consortium for Healthy Aging (NGI-NCHA), Leiden and Rotterdam, The Netherlands.
Luke C PillingEpidemiology and Public Health Group, Medical School, University of Exeter, Exeter, United Kingdom.
Katharina SchrammInstitute of Human Genetics, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany; Institute of Human Genetics, Technische Universität München, München, Germany.
Claudia SchurmannDepartment of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany; The Charles Bronfman Institute for Personalized Medicine, Genetics of Obesity & Related Metabolic Traits Program, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Brian H ChenThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, United States of America; The Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States of America.
Chunyu LiuThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, United States of America; The Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States of America.
Roby JoehanesThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, United States of America; The Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States of America; Mathematical and Statistical Computing Laboratory, Center for Information Technology, National Institutes of Health, Bethesda, Maryland, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; Hebrew SeniorLife, Boston, Boston, Massachusetts, United States of America.
Andrew D JohnsonThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, United States of America; Cardiovascular Epidemiology and Human Genomics Branch, Division of Intramural Research, National Heart, Lung and Blood Institute, Bethesda, Maryland, United States of America.
Chen YaoThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, United States of America; The Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States of America.
Sai-Xia YingMathematical and Statistical Computing Laboratory, Center for Information Technology, National Institutes of Health, Bethesda, Maryland, United States of America.
Paul CourchesneThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, United States of America; The Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States of America.
Lili MilaniEstonian Genome Center, University of Tartu, Tartu, Estonia.
Nalini RaghavachariDivision of Geriatrics and Clinical Gerontology National Institute on Aging, Bethesda, Maryland, United States of America.
Richard WangGenomics Core facility Genetics & Developmental Biology Center, National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States of America.
Poching LiuGenomics Core facility Genetics & Developmental Biology Center, National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States of America.
Eva ReinmaaEstonian Genome Center, University of Tartu, Tartu, Estonia.
Abbas DehghanNetherlands Genomics Initiative-sponsored Netherlands Consortium for Healthy Aging (NGI-NCHA), Leiden and Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands.
Albert HofmanNetherlands Genomics Initiative-sponsored Netherlands Consortium for Healthy Aging (NGI-NCHA), Leiden and Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands.
André G UitterlindenDepartment of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands; Netherlands Genomics Initiative-sponsored Netherlands Consortium for Healthy Aging (NGI-NCHA), Leiden and Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands.
Dena G HernandezLaboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, United States of America.
Stefania BandinelliGeriatric Unit, Azienda Sanitaria Firenze, Florence, Italy.
Andrew SingletonLaboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, United States of America.
David MelzerEpidemiology and Public Health Group, Medical School, University of Exeter, Exeter, United Kingdom.
Andres MetspaluEstonian Genome Center, University of Tartu, Tartu, Estonia.
Maren CarstensenInstitute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany; German Center for Diabetes Research (DZD e.V.), Partner Düsseldorf, Düsseldorf, Germany.
Harald GrallertResearch Unit of Molecular Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany; Institute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany; German Center for Diabetes Research (DZD e.V.), Partner Munich, Munich, Germany.
Christian HerderInstitute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany; German Center for Diabetes Research (DZD e.V.), Partner Düsseldorf, Düsseldorf, Germany.
Thomas MeitingerInstitute of Human Genetics, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany; Institute of Human Genetics, Technische Universität München, München, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Annette PetersInstitute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany; German Center for Diabetes Research (DZD e.V.), Partner Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
Michael RodenInstitute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany; German Center for Diabetes Research (DZD e.V.), Partner Düsseldorf, Düsseldorf, Germany; Division of Endocrinology and Diabetology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
Melanie WaldenbergerResearch Unit of Molecular Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany; Institute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
Marcus DörrUniversity Medicine Greifswald, Department of Internal Medicine B-Cardiology, Greifswald, Germany; DZHK (German Center for Cardiovascular Research), partner site Greifswald, Greifswald, Germany.
Stephan B FelixUniversity Medicine Greifswald, Department of Internal Medicine B-Cardiology, Greifswald, Germany; DZHK (German Center for Cardiovascular Research), partner site Greifswald, Greifswald, Germany.
Tanja ZellerUniversitäres Herzzentrum Hamburg, Hamburg, Germany; DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Hamburg, Germany.
International Consortium for Blood Pressure GWAS (ICBP)
Ramachandran VasanThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, United States of America.
Christopher J O'DonnellThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, United States of America; The Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States of America.
Peter J MunsonMathematical and Statistical Computing Laboratory, Center for Information Technology, National Institutes of Health, Bethesda, Maryland, United States of America.
Xia YangDepartment of Integrative Biology and Physiology, University of California, Los Angeles, Los Angeles, California, United States of America.
Holger ProkischInstitute of Human Genetics, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany; Institute of Human Genetics, Technische Universität München, München, Germany.
Uwe VölkerDepartment of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany; DZHK (German Center for Cardiovascular Research), partner site Greifswald, Greifswald, Germany.
Joyce B J van MeursDepartment of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands; Netherlands Genomics Initiative-sponsored Netherlands Consortium for Healthy Aging (NGI-NCHA), Leiden and Rotterdam, The Netherlands.
Luigi FerrucciIntramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, United States of America.
Daniel LevyThe National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, United States of America; The Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States of America.
National Heart Lung and Blood Institute · USFramingham Heart Study · USHelmholtz Zentrum München · DEUniversitätsmedizin Greifswald · DEUniversity of Tartu · EEDeutsches Diabetes-Zentrum e.V. · DEErasmus University Rotterdam · NLNational Institutes of Health · USNational Institute on Aging · USNetherlands Consortium for Healthy Ageing · NLUniversity of Exeter · GBAzienda Sanitaria di Firenze · ITCenter for Information Technology · USGerman Center for Diabetes Research · DEGerman Centre for Cardiovascular Research · DEHeinrich Heine University Düsseldorf · DEUniversity of California, Los Angeles · US

Funding

Cardiovascular Genomics and Bioinformatics projectsZIAHL006170 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI JOHNSON, ANDREW · 2013 to 2025
$25.3M
Genomic Epidemiology of Cardiovascular DiseaseZIAHL006002 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI O'DONNELL, CHRISTOPHER · 2009 to 2015
$8.0M
Statistical And Computational Methods For Gene Expression and Proteomic AnalysisZIACT000266 · CIT · CENTER FOR INFORMATION TECHNOLOGY · PI MUNSON, PETER J · 2009 to 2016
$4.2M
Gene Expression for Functional Genomics in Human PopulationsZIAHL006175 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI O'DONNELL, CHRISTOPHER · 2013 to 2015
$2.2M
Functional Genetic Variation Underlying Cardiovascular Genomic EpidemiologyZIAHL006173 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI O'DONNELL, CHRISTOPHER · 2013 to 2015
$2.0M
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
NHLBI NIH HHS N01 HC025195NHLBI NIH HHS N01-HC-25195Wellcome TrustWellcome Trust WT097835MF
6 · The paper itself

Abstract

Genome-wide association studies (GWAS) have uncovered numerous genetic variants (SNPs) that are associated with blood pressure (BP). Genetic variants may lead to BP changes by acting on intermediate molecular phenotypes such as coded protein sequence or gene expression, which in turn affect BP variability. Therefore, characterizing genes whose expression is associated with BP may reveal cellular processes involved in BP regulation and uncover how transcripts mediate genetic and environmental effects on BP variability. A meta-analysis of results from six studies of global gene expression profiles of BP and hypertension in whole blood was performed in 7017 individuals who were not receiving antihypertensive drug treatment. We identified 34 genes that were differentially expressed in relation to BP (Bonferroni-corrected p<0.05). Among these genes, FOS and PTGS2 have been previously reported to be involved in BP-related processes; the others are novel. The top BP signature genes in aggregate explain 5%-9% of inter-individual variance in BP. Of note, rs3184504 in SH2B3, which was also reported in GWAS to be associated with BP, was found to be a trans regulator of the expression of 6 of the transcripts we found to be associated with BP (FOS, MYADM, PP1R15A, TAGAP, S100A10, and FGBP2). Gene set enrichment analysis suggested that the BP-related global gene expression changes include genes involved in inflammatory response and apoptosis pathways. Our study provides new insights into molecular mechanisms underlying BP regulation, and suggests novel transcriptomic markers for the treatment and prevention of hypertension.

Indexed as

Genome-Wide Association StudyBlood PressureGene Expression RegulationGenetic Predisposition to DiseaseGenotypeHumansHypertensionPolymorphism, Single NucleotideTranscriptome

Identifiers

PMID25785607
PMCPMC4365001
OpenAlexW2029910307

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.